Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the first quarter of 2024.
- First-quarter revenue was $1.62 billion, which is up 5% on a reported basis and 7% at constant currency
- Women’s Health revenue increased by 11% and Biosimilars revenue climbed by 46%
- Meanwhile, Established Brands revenue was flat on an as-reported basis during the quarter
- Reported earnings per share and adjusted earnings per share were $0.78 and $1.22, respectively, during the three months
- Net income came in at $201 million in the March quarter and adjusted EBITDA was $538 million
- Gross margin was 59.0% on a reported basis and 62.1% on an adjusted basis in the first quarter
- Adjusted EBITDA margin dropped to 33.2% in the first quarter from 33.7% last year
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
NVDA Earnings: Nvidia Q1 2025 profit jumps and beats estimates; guides Q2
GPU behemoth NVIDIA Corporation (NASDAQ: NVDA) on Wednesday reported a multi-fold increase in first-quarter earnings, reflecting continued strong revenue growth. The results also topped expectations. The tech firm's revenues climbed
Salesforce (CRM) is preparing to report Q1 earnings. Here’s what to expect
Salesforce, Inc. (NYSE: CRM), a leading provider of cloud-based customer relationship management services, has delivered stable revenue growth in recent years, both organically and supported by acquisitions. The company’s near-term
A few points to note on Lowe’s (LOW) performance in Q1 2024
Shares of Lowe’s Companies Inc. (NYSE: LOW) were down over 1% on Wednesday. The stock has gained 9% over the past 12 months. The home improvement retailer reported its first
